sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
21-Apr-2014 12:33
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 401-425 out of 890.

<< < 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 > >>

Public Release: 29-Apr-2013
Dissertations and Features
Warning system predicts outbreaks of dengue fever
With the help of a warning system which measures the risk of dengue incidence using precipitation and air temperature, it is possible to forecast the outbreak of dengue fever up to 16 weeks in advance. This is what Yien Ling Hii concludes in the dissertation she is defending at Umeĺ University in Sweden on 3 May.

Contact: Yien Ling Hii
yienling.hii@umu.se
46-073-692-1345
Umea University

Public Release: 29-Apr-2013
Inventive: 102 bold new global health ideas win Grand Challenges Canada funding
59 innovators in 13 low and middle income countries and 43 in Canada will share $10.9 million in Canadian seed funding to pursue bold, creative ideas for tackling health problems in resource-poor parts of the world. The grants will advance 102 out-of-the-box innovations in remote diagnostics and monitoring, health protection, drug and vaccine development and accessibility, and other key health areas.

Contact: Terry Collins
tc@tca.tc
416-538-8712
Sandra Rotman Centre for Global Health

Public Release: 26-Apr-2013
International Liver Congress 2013
Developments in TACE and SIRT treatment in patients
Data from a number of clinical trials presented today at the International Liver Congress™ 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-079-001-38904
European Association for the Study of the Liver

Public Release: 26-Apr-2013
Gastroenterology
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
Gilead Sciences

Contact: Joseph Carey
jcarey@txbiomed.org
210-258-9437
Texas Biomedical Research Institute

Public Release: 25-Apr-2013
A*STAR, Veredus create market's first lab-on-chip to detect multiple tropical infectious diseases
The Agency for Science, Technology and Research and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample.
Agency for Science, Technology and Research

Contact: Dr. Sarah Chang
chang_kai_chen@a-star.edu.sg
65-682-66442
Agency for Science, Technology and Research (A*STAR), Singapore

Public Release: 25-Apr-2013
International Liver Congress 2013
New studies prove lethal link between alcohol, weight
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-079-001-38904
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
Direct-acting antivirals now ready for prime time
New data from a number of clinical trials presented for the first time at the International Liver Congress™ 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents for the treatment of hepatitis C.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-790-013-8904
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
NASH diagnosis set to improve with non-invasive tool
A Chinese study presented at the International Liver CongressTM 2013 has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis diagnosis.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-079-001-38904
European Association for the Study of the Liver

Public Release: 23-Apr-2013
AfriCoLeish receives funding boost from European Union
Research and development project, AfriCoLeish, is supported by the European Union Seventh Framework Programme through a grant of €3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan.
European Union

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 17-Apr-2013
7th Annual Sickle Cell Disease Research and Educational Symposium
Anti-sickling therapies should be focus for sickle cell science
Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 17-Apr-2013
Science Translational Medicine
HIV-infected moms who breastfeed exclusively have lower levels of virus in breast milk
HIV-infected women in sub-Saharan Africa who fed their babies exclusively with breast milk for more than the first four months of life had the lowest risk of transmitting the virus to their babies through breast milk. Women who stopped breast feeding earlier than four months had the highest concentrations of HIV in their breast milk, and those who continued to breastfeed, but not exclusively, had concentration levels in-between the two practices.

Contact: stephanie berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 16-Apr-2013
mBio
TGen-led study discovers dramatic changes in bacteria following male circumcision
Male circumcision reduces the abundance of bacteria living on the penis and might help explain why circumcision offers men some protection against HIV, according to a study led by the Translational Genomics Research Institute.
National Institutes of Health, Northern Arizona University

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 16-Apr-2013
mBio
Haiti cholera mutations could lead to more severe disease
The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 15-Apr-2013
Proceedings of the National Academy of Sciences
La Jolla Institute's surprising finding could alter the face of dengue vaccine development
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine.

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Public Release: 11-Apr-2013
Proceedings of the National Academy of Sciences
Discovery points to new approach to fight dengue virus
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
National Institutes of Health

Contact: Emil Venere
venere@purdue.edu
765-494-4709
Purdue University

Public Release: 11-Apr-2013
Polio eradication is achievable by 2018 and urgent, declare 400+ global scientists
Hundreds of scientists and technical experts from 80 countries historically launched the Scientific Declaration on Polio Eradication on 11 Apr. 2013. The world has never been closer to a world free from polio. At this unique moment, scientists have come together to stress the achievability of polio eradication and endorse the Eradication and Endgame Strategic Plan, a new strategy by the Global Polio Eradication Initiative to reach and sustain eradication.

Contact: Dan Pawson
dpawson@globalhealthstrategies.com
718-873-3169
Global Health Strategies

Public Release: 11-Apr-2013
Leading organizations back Global Action Plan
More than 100 nongovernmental organizations and civil society organizations, joined by dozens of leading experts, expressed their support today for the World Health Organization and UNICEF's first-ever global plan to simultaneously tackle pneumonia and diarrhoea -- diseases that take the lives of almost two million children each year -- and urged governments and their partners to make the plan a reality.

Contact: Guillermo Meneses
Guillermo.Meneses@gmmb.com
202-445-1570
PATH

Public Release: 11-Apr-2013
Cell
Cell-destroyer that fights and promotes TB reveals what's behind its split identity
TB can be a disease not only of failed immunity but also of excessive immune response. Tumor necrosis factor -- normally an infection-fighting substance produced by the body -- can actually heighten susceptibility to tuberculosis if its levels are too high.
National Institutes of Health, Northwest Regional Center of Excellence for Biodefense

Contact: Leila Gray
leilag@uw.edu
206-685-0381
University of Washington

Public Release: 11-Apr-2013
Nature
Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology
The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants grown in Asia and Africa. On Apr. 11, Sanofi will launch the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris from discoveries in the laboratory of Jay Keasling at UC Berkeley.
Gates Foundation

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley

Public Release: 10-Apr-2013
Journal of Development and Behavioral Pediatrics
Training gives kids of AIDS patients a leg up
A simple in-home training program for caregivers can give children of AIDS patients a better shot at prosperity by improving their early-childhood development, according to a study led by a Michigan State University researcher.
National Institutes of Health

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-420-1908
Michigan State University

Public Release: 10-Apr-2013
BMJ
In an economic crash, public health improves
The economic crash in Cuba following the fall of the Soviet Union has provided researchers with a unique natural experiment on obesity, diabetes and heart disease, according to a study in the British Medical Journal.

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System

Public Release: 10-Apr-2013
Bulletin of the World Health Organization
Researchers develop tool to assist areas of infectious disease outbreaks
Researchers have developed a simple new tool to help governments worldwide decide whether to screen airplane passengers leaving or arriving from areas of infectious disease outbreaks.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 10-Apr-2013
DNDi Latin America pledges 2013 Carlos Slim Health Award to chagas disease
The Drugs for Neglected Diseases initiative Latin America today announced that it will pledge the US $100,000 Carlos Slim Health Award to Chagas disease, the leading parasitic killer of the Americas.

Contact: Betina Moura
bmoura@dndi.org
55-218-122-4166
Drugs for Neglected Diseases Initiative

Public Release: 10-Apr-2013
Proceedings of the Royal Society B
Fighting disease from within the mosquito: New techniques to help halt the spread of disease
Scientists have revealed a new technique to introduce disease-blocking bacteria into mosquitoes, with promising results that may halt the spread of diseases such as dengue, yellow fever and potentially malaria.

Contact: Nerissa Hannink
nhannink@unimelb.edu.au
61-430-588-055
University of Melbourne

Public Release: 9-Apr-2013
Circulation
'Diseases of affluence' spreading to poorer countries
High blood pressure and obesity are no longer confined to wealthy countries, a new study has found.
Medical Research Council, NIH/National Institute for Health Research Imperial Biomedical Research Centres

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Showing releases 401-425 out of 890.

<< < 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 > >>